Oral L-Carnitine Supplementation and Exercise Performance
Abstract
Carnitine is an endogenous compound essential for energy production, playing dual roles as a component of fatty acid translocation through the mitochondrial membrane and as a buffer for accumulating acetyl CoA. In addition, it has been shown to improve muscle recovery and up-regulate androgen receptors, and has various effects on the brain. In the absence of either primary or secondary deficiencies, it is rare for healthy individuals to become deficient in carnitine. Studies have found that chronic training causes decreases in muscle carnitine concentration below baseline; thus, supplementation is recommended to at least stabilize carnitine levels. In this project, we review clinical studies that assess the effect carnitine has on exercise performance and metabolism in aerobic, anaerobic, and resistance training. Although findings have been inconsistent, research has demonstrated carnitine’s ability to improve exercise performance by increasing fatty acid oxidation, sparing glycogen, reducing lactate accumulation, increasing efficiency of glycogen utilization, decreasing rate of perceived exertion, and allowing a higher work output. We conclude that chronic ingestion of ~30 mg/kg/d of L-carnitine taken with carbohydrates can effectively increase muscle total carnitine concentration, enabling its ergogenic effects. More studies are necessary to determine optimal dosing of L-carnitine, the optimal dose of carbohydrates with L-carnitine, and the effect of L-carnitine on chronic training. No prior study has investigated the effect of chronic L-carnitine supplementation on chronic resistance training. We propose a 24-week parallel design, randomized, double-blind, placebo-controlled study. Participants will be healthy, resistance-trained men, observed to determine whether carnitine can be used to improve recovery, muscular endurance, and strength.Downloads
How to Cite
Issue
Section
License
Authors contributing to Revue YOUR Review agree to release their articles under one of three Creative Commons licenses: Creative Commons Attribution 4.0 International; Creative Commons Attribution-NonCommercial 4.0 International; or Creative Commons Attribution-NoDerivatives 4.0 International. All editorial content, posters, and abstracts on this site are licensed under Creative Commons Attribution-NoDerivatives 4.0 International. For further information about each license, see:
https://creativecommons.org/licenses/
In all cases, authors retain copyright of their work and grant the e-journal right of first publication. Authors are able to enter into other contractual arrangements for the non-exclusive distribution of the e-journal's published version of the article (e.g., post it to an institutional repository or publish it in a book or in another journal), with an acknowledgement of its initial publication in this e-journal.